Cochlear | COH - Sales Revenues

Stock Price
202.45
Daily Change
3.78 1.90%
Monthly
-24.36%
Yearly
-21.79%
Q1 Forecast
194.59

Cochlear reported AUD585.65M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
Avita Medical AUD 18.42M 14K Jun/2025
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Mesoblast USD 13.2M 10.04M Jun/2025
Monash IVF AUD 65.77M 74.54M Jun/2025
Nanosonics AUD 105.03M 11.44M Jun/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
Regis Healthcare AUD 619.06M 37.36M Dec/2024
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Somnomed AUD 45.11M 1.46M Dec/2023
Sonic Healthcare AUD 5.45B 470M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025